Provided by Tiger Fintech (Singapore) Pte. Ltd.

Haemonetics

64.08
-0.7200-1.11%
Volume:6.53K
Turnover:419.39K
Market Cap:3.22B
PE:25.24
High:64.30
Open:64.20
Low:64.05
Close:64.80
Loading ...

Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025

GlobeNewswire
·
03 Mar

KalVista Pharmaceuticals’ Sebetralstat: A Game-Changer in Oral HAE Treatment with Strong Market Potential

TIPRANKS
·
03 Mar

Haemonetics Q3 Operating Income USD 59 Million

THOMSON REUTERS
·
02 Mar

Haemonetics Q3 Gross Margin 55.5%

THOMSON REUTERS
·
02 Mar

Haemonetics Q3 Adjusted EPS USD 1.19 VS. Ibes Estimate USD 1.17

THOMSON REUTERS
·
02 Mar

Is BioCryst Pharmaceuticals, Inc. (BCRX) the Best Small-Cap Stock to Buy Now?

Insider Monkey
·
01 Mar

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack

StockStory
·
28 Feb

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

Business Wire
·
27 Feb

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress

GlobeNewswire
·
27 Feb

US Stocks That May Be Trading At A Discount In February 2025

Simply Wall St.
·
25 Feb

3 US Stocks That May Be Undervalued In February 2025

Simply Wall St.
·
24 Feb

KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

Business Wire
·
24 Feb

BioCryst Announces Positive Results from APeX-P Trial for ORLADEYO® (berotralstat) in Pediatric Patients with Hereditary Angioedema Aged 2 to <12 Years

GlobeNewswire
·
24 Feb

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

PR Newswire
·
24 Feb

3 US Stocks Estimated To Be Trading Below Their Intrinsic Values

Simply Wall St.
·
24 Feb

The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)

PR Newswire
·
24 Feb